{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:06:27Z","timestamp":1788498387875,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.toxicon.2005.08.010","type":"journal-article","created":{"date-parts":[[2005,9,29]],"date-time":"2005-09-29T11:16:43Z","timestamp":1127992603000},"page":"797-805","source":"Crossref","is-referenced-by-count":44,"title":["Pharmacokinetics of a F(ab\u2032)2 scorpion antivenom in healthy human volunteers"],"prefix":"10.1016","volume":"46","author":[{"given":"H.","family":"V\u00e1zquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ch\u00e1vez-Haro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Garc\u00eda-Ubbelohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mancilla-Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Paniagua-Sol\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alag\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sevcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2005.08.010_bib1","series-title":"National Institute of Health (NIH)","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults","author":"Anonymous","year":"1998"},{"key":"10.1016\/j.toxicon.2005.08.010_bib2","unstructured":"Anonymous 2005. Casos por entidad federativa de Enfermedades no Transmisibles hasta la semana epidemiol\u00f3gica 51 de 2004. http:\/\/www.dgepi.salud.gob.mx\/boletin\/2005\/sem01\/index.htm."},{"key":"10.1016\/j.toxicon.2005.08.010_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4269\/ajtmh.1999.61.259","article-title":"A new monospecific ovine FAB fragment antivenom for treatment of envenoming by the Sri Lankan Russell's viper","volume":"61","author":"Ariaratnam","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2005.08.010_bib4","first-page":"1512","article-title":"Pharmacokinetics of Vipera aspis venom after experimental envenomation in rabbits","volume":"268","author":"Audebert","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxicon.2005.08.010_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/taap.1997.8363","article-title":"Interspecies scaling of clearance and volume of distribution of horse antivenom F(ab\u2019)2","volume":"150","author":"Bazin-Redureau","year":"1998","journal-title":"Toxicol. App. Pharmacol."},{"key":"10.1016\/j.toxicon.2005.08.010_bib6","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/archinte.159.7.706","article-title":"Recurrent and persistent coagulopathy following pit viper envenomation","volume":"159","author":"Boyer","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.toxicon.2005.08.010_bib7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1067\/mem.2001.113134","article-title":"Recurrence phenomena following immunoglobulin therapy of snake envenomations. Part II: Guidelines for clinical management with crotaline Fab antivenom","volume":"37","author":"Boyer","year":"2001","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.toxicon.2005.08.010_bib8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0041-0101(98)00216-5","article-title":"Pharmacokinetics of the toxic fraction of Centruroides limpidus limpidus venom in experimentally envenomed rabbits and effects of immunotherapy with specific F(ab\u2019)2","volume":"37","author":"Calder\u00f3n-Aranda","year":"1999","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2005.08.010_bib9","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1001\/archinte.161.16.2030","article-title":"A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States","volume":"161","author":"Dart","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.toxicon.2005.08.010_bib10","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0041-0101(94)90383-2","article-title":"Scorpionism and serotherapy in Mexico","volume":"32","author":"Dehesa-Davila","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2005.08.010_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0041-0101(02)00331-8","article-title":"Relationship between plasmatic levels of various cytokines, tumour necrosis factor, enzymes, glucose and venom concentration following Tityus scorpion sting","volume":"41","author":"D'Suze","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2005.08.010_bib12","series-title":"Statistical Methods for Rates and Proportions","author":"Fleiss","year":"1973"},{"key":"10.1016\/j.toxicon.2005.08.010_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1081\/BIP-120008854","article-title":"Vz, the terminal phase volume: time for its terminal phase","volume":"11","author":"Gobburu","year":"2001","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/j.toxicon.2005.08.010_bib14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2165\/00003088-200342080-00002","article-title":"Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation","volume":"42","author":"Guti\u00e9rrez","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.toxicon.2005.08.010_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4269\/ajtmh.1990.42.260","article-title":"Pharmacokinetics of three commercial antivenoms in patients envenomed by the Malayan pit viper, Calloselasma rhodostoma, in Thailand","volume":"42","author":"Ho","year":"1990","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2005.08.010_bib16","series-title":"Nonparametric Statistical Procedures","author":"Hollander","year":"1973"},{"key":"10.1016\/j.toxicon.2005.08.010_bib17","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0041-0101(98)00144-5","article-title":"Pharmacokinetics of 125I-labelled IgG, F(ab\u2032)2 and F(ab) fractions of scorpion and snake antivenins: merits and potential for therapeutic use","volume":"36","author":"Ismail","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2005.08.010_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0041-0101(80)90009-4","article-title":"Pharmacokinetics of 125I-labelled venom from the scorpion Androctonus amoreuxi (Aud. and Sav.)","volume":"18","author":"Ismail","year":"1980","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2005.08.010_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0041-0101(83)90048-X","article-title":"Pharmacokinetics of 125I labeled anti venom to the venom from the scorpion Androctonus amoreuxi","volume":"21","author":"Ismail","year":"1983","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2005.08.010_bib20","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0041-0101(96)00055-4","article-title":"A three-compartment open pharmacokinetic model can explain variable toxicities of cobra venoms and their alpha toxins","volume":"34","author":"Ismail","year":"1996","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2005.08.010_bib21","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0041-0101(01)00083-6","article-title":"Effect of antivenom of Buthus occitanus tunetanus (Bot) scorpion venom pharmacokinetics: towards and optimization of antivenom immunotherapy in rabbit model","volume":"39","author":"Krifi","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2005.08.010_bib22","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/jps.20178","article-title":"Antibody pharmacokinetics and pharmacodynamics","volume":"93","author":"Lobo","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.toxicon.2005.08.010_bib23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1152\/physrev.1954.34.2.334","article-title":"Water and electrolyte metabolism","volume":"34","author":"Manery","year":"1954","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.toxicon.2005.08.010_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4269\/ajtmh.1997.56.291","article-title":"First clinical experiences with a new ovine Fab Echis oscelatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur serum (IPSER) Africa antivenom","volume":"56","author":"Mayer","year":"1997","journal-title":"A. J. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2005.08.010_bib25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/comjnl\/7.4.308","article-title":"A simplex method for function minimization","volume":"7","author":"Nelder","year":"1965","journal-title":"Comp. J."},{"key":"10.1016\/j.toxicon.2005.08.010_bib26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0041-0101(00)00204-X","article-title":"Clinical symptoms observed in children envenomed by scorpion stings, at children's hospital from the State of Morelos, Mexico","volume":"39","author":"Oasnaya-Romero","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2005.08.010_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0196-9781(94)90198-8","article-title":"Differential kinetics for immunoneutralization of circulating gastrin by gastrin monoclonal antibody and its Fab1 fragment in rats","volume":"15","author":"Ohning","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/j.toxicon.2005.08.010_bib28","first-page":"141","article-title":"Pharmacokinetics and toxicity of high doses of antibody Fab fragments in rats","volume":"16","author":"Pentel","year":"1988","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxicon.2005.08.010_bib29","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1023\/A:1016279219619","article-title":"Snake F(ab\u2032)2 antivenom from hyperimmunized horse: pharmacokinetics following intravenous and intramuscular administration","volume":"12","author":"P\u00e9pin","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.toxicon.2005.08.010_bib30","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0041-008X(96)80033-0","article-title":"Immunoreactivity and pharmacokinetics of horse anti-scorpion venom F(ab\u2019)2-scorpion venom interactions","volume":"141","author":"Pepin-Covata","year":"1996","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxicon.2005.08.010_bib31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1021\/js9701824","article-title":"Preclinical assessment of immunoreactivity of new purified equine F(ab\u2032)2 against European viper venom","volume":"87","author":"Pepin-Covata","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.toxicon.2005.08.010_bib32","first-page":"1","article-title":"Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy","volume":"281","author":"Rivi\u00e8re","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxicon.2005.08.010_bib33","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0022-3565(24)37451-8","article-title":"Absorpion and elimination of viper antivenom after antivenom administration","volume":"285","author":"Rivi\u00e8re","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxicon.2005.08.010_bib34","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0041-0101(96)00209-7","article-title":"Snakes and snakebite in Central America","volume":"35","author":"Russell","year":"1997","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2005.08.010_bib35","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0041-0101(96)00050-5","article-title":"Pharmacokinetics of Tityus serrulatus scorpion venom determined by enzyme-linked immunosorbent assay in the rat","volume":"34","author":"Santana","year":"1996","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2005.08.010_bib36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1067\/mem.2001.113135","article-title":"Recurrence phenomena after immunoglobulin therapy for snake envenomations: part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies","volume":"37","author":"Seifert","year":"2001","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.toxicon.2005.08.010_bib37","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.toxicon.2004.07.032","article-title":"Modelling Tityus scorpion venom and antivenom pharmacokinetics. Evidence of active immunoglobulin G's F(ab\u2019)2 extrusion mechanism from blood to tissues","volume":"44","author":"Sevcik","year":"2004","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2005.08.010_bib38","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0035-9203(85)90353-0","article-title":"Plasma clearance time of Russell's viper (Vipera russelli) antivenom in human snake byte victims","volume":"79","author":"Than","year":"1985","journal-title":"Trans. Roy. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2005.08.010_bib39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0041-0101(02)00393-8","article-title":"Report of a WHO workshop on the standardization and control of antivenoms","volume":"41","author":"Theakston","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2005.08.010_bib40","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.2042-7158.1991.tb03488.x","article-title":"The plasma kinetics of digoxin-specific Fab fragments and digoxin in the rabbit","volume":"43","author":"Timsina","year":"1991","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.toxicon.2005.08.010_bib41","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.2042-7158.1992.tb03208.x","article-title":"The plasma disposition and renal elimination of digoxin-specific Fab fragments and digoxin in the rabbit","volume":"44","author":"Timsina","year":"1992","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.toxicon.2005.08.010_bib42","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/00003088-199528060-00006","article-title":"Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicity","volume":"28","author":"Ujhelyi","year":"1995","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.toxicon.2005.08.010_bib43","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/clpt.1993.165","article-title":"Disposition of digoxin immune Fab in patients with kidney failure","volume":"54","author":"Ujhelyi","year":"1993","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010105002977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010105002977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T16:34:33Z","timestamp":1736008473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010105002977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0041010105002977"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2005.08.010","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}